Previous close | 29.00 |
Open | 29.80 |
Bid | 29.60 x 40000 |
Ask | 30.40 x 40000 |
Day's range | 29.80 - 29.80 |
52-week range | 17.40 - 30.60 |
Volume | |
Avg. volume | 45 |
Market cap | 88.992B |
Beta (5Y monthly) | 0.80 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.14 (0.48%) |
Ex-dividend date | 28 Sept 2023 |
1y target est | N/A |
"For what purpose was Masa Son born? It may sound strange, but I think I was born to realize ASI," SoftBank's CEO said.
TOKYO (Reuters) -Japanese technology investor SoftBank Group has launched a joint venture with Tempus AI that aims to analyse personal medical data with artificial intelligence (AI) to come up with treatment recommendations, chief executive officer Masayoshi Son told a briefing in Tokyo. This is the latest in a string of AI investments SoftBank has recently announced as it increases the pace of its investment activity after a muted few years. SoftBank invested around $200 million in Tempus in its series G funding round in April before Tempus listed on the Nasdaq in June.
SoftBank will make this investment as part of a larger $250 million funding round, the report said, citing people familiar with the matter. Perplexity declined to comment, while SoftBank did not respond to a Reuters' request for comment. Perplexity's search tools enable users to get instant answers to questions with sources and citations.